Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5189]

Stem-cell niche for 10 billion colon cells a day

Stem-cell niche for 10 billion colon cells a day

ASCO 2018: Interim results from clinical trial of immunotherapy for glioblastoma show significant clinical benefit

ASCO 2018: Interim results from clinical trial of immunotherapy for glioblastoma show significant clinical benefit

Personalised cancer vaccine may increase long-term survival in patients with deadly brain cancer

Personalised cancer vaccine may increase long-term survival in patients with deadly brain cancer

New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments

New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments

European Commission issues authorisation of rucaparib for women with recurrent ovarian cancer

European Commission issues authorisation of rucaparib for women with recurrent ovarian cancer

Male thyroid cancer survivors face 50 percent higher risk of heart disease than women

Male thyroid cancer survivors face 50 percent higher risk of heart disease than women

Nanoparticle drug doubles lifetime of animal models in preclinical trials

Nanoparticle drug doubles lifetime of animal models in preclinical trials

Novel RNA-modifying tool corrects genetic diseases

Novel RNA-modifying tool corrects genetic diseases

Cilia on cells adjacent to tumours can impact signalling that influences cancer growth and response to treatment

Cilia on cells adjacent to tumours can impact signalling that influences cancer growth and response to treatment

Genome's dark matter offers clues to major challenge in prostate cancer

Genome's dark matter offers clues to major challenge in prostate cancer

More from ecancer